Adults with Type 2 Diabetes who are struggling to reach their blood sugar goals despite multiple medications may qualify for a clinical research study evaluating an investigational oral treatment designed to address cortisol-related factors that may contribute to diabetes.
Adults with type 2 diabetes and increased cardiovascular risk who are not achieving adequate blood sugar control with oral diabetes medications may qualify for a clinical research study evaluating an investigational weekly injectable medication.
Individuals with Graves’ disease who continue to require treatment with methimazole may qualify for a research study evaluating an investigational medication.
Adults with osteoarthritis (OA) knee pain may qualify for a research study evaluating an investigational medication for chronic pain relief.